EQRx International, Inc.
4 clinical trials · Sponsor
◉ Watch EQRx International, Inc.
| Record | Firm | Date |
|---|---|---|
| Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer (NCT05712941) | EQRx International, Inc. | 2023-04-18 |
| Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer (NCT05493501) | EQRx International, Inc. | 2022-12-14 |
| An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143 (NCT05199610) | EQRx International, Inc. | 2022-03-30 |
Track EQRx International, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.